Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
750 participants
OBSERVATIONAL
2015-10-15
2016-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal Swabs
NCT03596151
A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test
NCT00682851
Trichomonas Vaginalis Repeat Infections Among HIV Negative Women
NCT01832480
Bacterial Vaginosis Home Screening to Prevent STDs
NCT00667368
Endosymbionts in Trichomonas Vaginalis Pathogenicity
NCT07082127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Symptomatic
Subjects will be categorized by the clinician as symptomatic for Trichomonas vaginalis infection.
Solana Trichomonas Assay Testing
Specimen collection of urine and/or vaginal swabs for testing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Solana Trichomonas Assay Testing
Specimen collection of urine and/or vaginal swabs for testing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Symptoms in women can include:
* Greenish-yellow, frothy vaginal discharge with a strong odor
* Painful urination
* Vaginal itching and irritation
* Discomfort during intercourse
* Lower abdominal pain (rare)
Exclusion Criteria
2. At clinical sites informed consent, unable to understand and consent to participation; for minors this includes parent or legal guardian.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Quidel Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
University of North Carolina, Div. of Infectious Diseases
Chapel Hill, North Carolina, United States
University of Washington in Seattle
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TV-01-2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.